Biotech - Press Releases

Date	Title	Company
05-Dec-2019	Statement from Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research, on impurities found in diabetes drugs outside the U.S.	U.S. Food and Drug Administration
05-Dec-2019	The Lawrence J. Ellison Institute for Transformative Medicine of USC Welcomes Anna Barker	The Lawrence J. Ellison Institute for Transformative Medicine of USC
05-Dec-2019	Inceptua appoints new President North America	Inceptua
05-Dec-2019	Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research	Cannabics Pharmaceuticals Inc.
05-Dec-2019	Astellas and MBC BioLabs Announce Golden Ticket Winners - Supporting Biotech Start-Ups to Accelerate Innovative Science	Astellas
05-Dec-2019	Lessons from EU Medical Device Regulation compliance preparations	Kallik
05-Dec-2019	Internet of Medical Things - the Latest Developments	SMi Group Ltd
05-Dec-2019	Biologics Market Size to Upsurge Based on Increasing Occurrence of Long-Lasting Sicknesses Till 2025 \| Million Insights	Million Insights
05-Dec-2019	Ardelyx Announces Pricing of Upsized Public Offering of Common Stock	Ardelyx
04-Dec-2019	RubrYc Therapeutics Announces formation of its Scientific Advisory Board	RubrYc Therapeutics, Inc.
04-Dec-2019	Benchling Joins the AWS Partner Network Global Startups Program	Benchling
04-Dec-2019	New global survey shows misperceptions about lung cancer among the general public	Lung Ambition Alliance
04-Dec-2019	ASLAN PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES	ASLAN Pharmaceuticals
04-Dec-2019	Micro-Leads Announces $10M in Funding for Precision Neuromodulation Therapy	Albany Med
04-Dec-2019	Volker Koscielny, new Chief Medical Officer and new member of the Management Board at Almirall	Almirall
04-Dec-2019	Interview Released Stefan Przyborski, Chairman for SMi’s 3D Cell Culture Conference 2020	SMi Group
04-Dec-2019	Chiesi outlines €350 million investment and announces the development of the first carbon minimal pressurised Metered Dose Inhaler (pMDI) for Asthma and COPD	Chiesi Group
04-Dec-2019	Kancera reports in-depth analysis of the Phase Ib program with KAND567, showing the desired effect on the human immune system	Kancera AB
04-Dec-2019	MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs	MaxCyte, Inc.
04-Dec-2019	Aqilion strengthens its portfolio with two innovative pharmaceutical projects in the fields of inflammation and oncology	AQILION AB